Answers · Valuation & Worth
Can we use patents as collateral for a loan? How do lenders value them?
Updated June 2026
The short answer
Yes. Patents can secure financing, and a growing set of specialist lenders, venture debt funds, and insurance-backed programs lend against them. Expect conservative terms: published programs commonly advance only a fraction of appraised value, and the entry ticket is a lending-grade valuation, which at ipCG typically starts at $50,000.
Lenders think in liquidation terms. The question their credit committee asks is what the collateral would fetch in a default sale to a third party, which is a harder test than what the patents are worth in your hands.
How IP-backed lending works
The structures vary. Venture debt routinely takes an all-asset lien that sweeps in IP without pricing it separately. True IP-backed loans, where the patents are the primary collateral, come mostly from specialist lenders and funds rather than commercial banks, and an emerging segment wraps the loan in collateral protection insurance, where an insurer effectively guarantees a floor value for the IP. Several governments outside the US run published IP-financing programs as well, and the insurance-wrapped model has been growing in the US market.
Mechanically, the lender perfects a security interest in the patents, with filings and recordation your counsel handles. We are a consultancy, not a law firm: the security agreement, the perfection steps, and the default mechanics are legal work, and the accounting treatment of the facility belongs with your accountants.
How lenders actually value patent collateral
Differently from anyone else. An investor values your patents in your hands, with your products and your execution. A lender values them in someone else's hands after things have gone wrong, so transferable value dominates: would another operator or licensee pay for these assets, at what discount, and how fast. Existing royalty streams are the strongest collateral feature because they are cash flows that survive a transfer. Evidence of use against third-party products comes next, since it travels with the patent.
This is why advance rates on IP run conservative and why the valuation has to be built for the purpose. A fundraising valuation that assumes your roadmap succeeds will be discarded by a credit committee; a lending-grade analysis values the assets under orderly and distressed transfer scenarios, with the assumptions documented for the committee to test.
What it takes to qualify
Clean recorded title with no gaps in the assignment chain, maintenance fees current, no prior exclusive licenses that hollow out what a transferee would receive, and demonstrable transfer value through royalties, evidence of use, or an active market for the technology. Then the documented valuation itself, which for lending support sits in our transaction-grade tier starting around $50,000, with details on our pricing page. Lenders and insurers frequently commission or require independent analysis at this level, and our ipValue Model has supported more than $2 billion in cumulative transaction value across uses like these.
Related questions
Will a regular commercial bank lend against our patents?
Rarely as primary collateral. Banks lack the infrastructure to value or liquidate IP, so they treat it as unpriced upside inside an all-asset lien. Priced IP lending comes from specialist lenders, venture debt funds, and insurance-backed programs.
What happens to our patents if we default?
The lender can foreclose on the collateral and sell or license it, subject to the security agreement. The mechanics and your protections are legal questions for your counsel before signing, not after.
Do existing licenses help or hurt the collateral value?
Royalty-bearing non-exclusive licenses usually help, because they are transferable cash flow. A broad exclusive license usually hurts, because it strips what a buyer in foreclosure would actually receive. Lenders read the license stack carefully, so know yours before they do.
Is the valuation worth it if the loan is not certain?
Scope it against the financing size. A lending-grade valuation starting around $50,000 makes sense for a multi-million dollar facility, and the same analysis typically gets reused for licensing, M&A readiness, and board reporting.
Find out if your portfolio is bankable
Tell us about the assets and the financing you have in mind. We will give you a straight read on whether a lending-grade valuation is worth pursuing. Discovery calls are free.
Talk with Our TeamRelated
ipCapital Group is a consultancy, not a law firm, and nothing on this page is legal advice. Dollar figures on this page are typical market ranges for professional IP services, drawn from published sources and industry experience across a variety of providers. They are not an ipCG quote or rate card; every ipCG engagement is individually scoped and priced. See how our pricing works.